Synergistic Effect of Static Compliance and D-dimers to Predict Outcome of Patients with COVID-19-ARDS: A Prospective

Tommaso Tonetti1, Giacomo Grasselli2,3, Paola Rucci4

  • 1Dipartimento di Scienze Mediche e Chirurgiche (DIMEC), Anesthesia and Intensive Care Medicine, IRCCS Policlinico di Sant'Orsola, Università di Bologna, 40138 Bologna, Italy.

Biomedicines
|September 28, 2021
PubMed

Insights

High D-dimer and low static compliance in COVID-19-ARDS patients indicate a high mortality risk. This combination identifies a specific patient group with significantly increased 28-day mortality, aiding in risk stratification.

Area of Science:

  • Critical Care Medicine
  • Pulmonology
  • Hematology

Background:

  • COVID-19-associated Acute Respiratory Distress Syndrome (ARDS) presents complex injury patterns.
  • D-dimer levels reflect thrombotic/vascular injury, while static compliance indicates parenchymal lung injury.

Purpose of the Study:

  • To evaluate the combined predictive value of D-dimer and static compliance for mortality in COVID-19-ARDS.
  • To identify specific patient phenotypes based on these markers.

Main Methods:

  • Retrospective analysis of adult patients with COVID-19-ARDS from two distinct time periods (training and testing samples).
  • D-dimer and static compliance measured within 24 hours of invasive ventilation.
  • Receiver operating characteristic (ROC) curve analysis and classification tree analysis (chi-square automatic interaction detection) were used to define groups.
  • Cox regression analysis, adjusted for SOFA, sex, age, and PaO2/FiO2 ratio, assessed 28-day all-cause mortality.

Main Results:

  • Three distinct groups were identified: low D-dimer (LD), high D-dimer/high compliance (LD-HC), and high D-dimer/low compliance (HD-LC).
  • 28-day mortality progressively increased across these groups (24-35-57% in training; 27-39-60% in testing).
  • The HD-LC group demonstrated significantly higher adjusted mortality compared to the LD group (HR=0.479) and the LD-HC group (HR=0.542).

Conclusions:

  • The combination of elevated D-dimer and low static compliance identifies a high-risk clinical phenotype in COVID-19-ARDS patients.
  • This phenotype is associated with significantly increased 28-day mortality.
  • These findings can aid in risk stratification and clinical management of COVID-19-ARDS.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
74
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
46
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
443
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
122
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
77